Yang Gi Hoon, Kang Donggu, An SangHyun, Ryu Jeong Yeop, Lee KyoungHo, Kim Jun Sik, Song Moon-Yong, Kim Young-Sik, Kwon Sang-Mo, Jung Won-Kyo, Jeong Woonhyeok, Jeon Hojun
Research Institute of Additive Manufacturing and Regenerative Medicine, Baobab Healthcare Inc, 55 Hanyangdaehak-Ro, Ansan, Gyeonggi-Do, 15588, South Korea.
Preclinical Research Center, K Medi-hub, 80 Cheombok-ro, Dong-gu, Daegu, 41061, South Korea.
Biomater Res. 2022 Dec 5;26(1):73. doi: 10.1186/s40824-022-00321-2.
Until recent, there are no ideal small diameter vascular grafts available on the market. Most of the commercialized vascular grafts are used for medium to large-sized blood vessels. As a solution, vascular tissue engineering has been introduced and shown promising outcomes. Despite these optimistic results, there are limitations to commercialization. This review will cover the need for extrusion-based 3D cell-printing technique capable of mimicking the natural structure of the blood vessel. First, we will highlight the physiological structure of the blood vessel as well as the requirements for an ideal vascular graft. Then, the essential factors of 3D cell-printing including bioink, and cell-printing system will be discussed. Afterwards, we will mention their applications in the fabrication of tissue engineered vascular grafts. Finally, conclusions and future perspectives will be discussed.
直到最近,市场上还没有理想的小直径血管移植物。大多数商业化的血管移植物用于中大型血管。作为一种解决方案,血管组织工程已被引入并显示出有前景的结果。尽管有这些乐观的结果,但在商业化方面仍存在局限性。本综述将涵盖对能够模仿血管自然结构的基于挤压的3D细胞打印技术的需求。首先,我们将强调血管的生理结构以及理想血管移植物的要求。然后,将讨论3D细胞打印的基本要素,包括生物墨水和细胞打印系统。之后,我们将提及它们在组织工程血管移植物制造中的应用。最后,将讨论结论和未来展望。